-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Downgrades Traws Pharma to Neutral, Announces $1 Price Target

Benzinga·06/18/2026 12:04:04
Listen to the news
HC Wainwright & Co. analyst Brandon Folkes downgrades Traws Pharma (NASDAQ:TRAW) from Buy to Neutral and announces $1 price target.